{"nct_id":"NCT04506086","title":"Feasibility Study to Evaluate Outpatient Blinatumomab in Subjects With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic Leukemia (ALL)","status":"TERMINATED","status_verified_date":"2025-04","start_date":"2021-08-26","start_date_type":"ACTUAL","primary_completion_date":"2024-07-04","primary_completion_date_type":"ACTUAL","completion_date":"2024-09-16","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["AMGN"]}